ReviewFrontiers in pharmacology2018
Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries.
Review in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Knowledge, practices, and recognition ability of counterfeit medicines among lebanese community pharmacists during concurrent national crises.Scientific reports · 2025Article
- Post-market quality monitoring of medicines in Christian Health Association of Ghana health institutions.Ghana medical journal · 2025Article
- Economic barriers to prevent the smuggling of health goods in Iran.BMJ global health · 2024Article
- An open-source smartphone app for the quantitative evaluation of thin-layer chromatographic analyses in medicine quality screening.Scientific reports · 2022Article
- Augmenting Product Defect Surveillance Through Web Crawling and Machine Learning in Singapore.Drug safety · 2021Article
- Implementing pharmaceutical track-and-trace systems: a realist review.BMJ global health · 2021Article
- Tackling the blind spot of poor-quality medicines in Universal Health Coverage.Journal of pharmaceutical policy and practice · 2020Review
- Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations.Journal of pharmaceutical policy and practice · 2019Review
- Unintended Consequences and Hidden Obstacles in Medicine Access in Sub-Saharan Africa.Frontiers in public health · 2019Article
- Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines.The journal of medicine accessArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Substandard and falsified (SF) medicines have emerged as a global public health issue within the last two decades especially in low- and middle-income countries (LMICs). Serious consequences of this problem include a loss of trust and increased financial costs due to less disease control and more frequent complications during therapy. Of note, antimicrobial resistance is an additional long-term implication of poor-quality antimicrobials. This review covers information technology tools including medicines authentication tools (MAT) as mobile apps and messaging service, 2D barcoding approaches with drug safety alert systems, web based drug safety alerts, radiofrequency identification tags, databases to support visual inspection, digital aids to enhance the performance of quality evaluation kits, reference libraries for identification of falsified and substandard medicines, and quality evaluation kits based on machine learning for field testing. While being easy to access and simple to use, these initiatives are gaining acceptance in LMICs. Implementing 2D barcoding based on end-to-end verification and "Track and Trace" systems has emerged as a step toward global security in the supply chain. A breakthrough in web-based drug safety alert systems and data bases was the establishment of the Global Surveillance and Monitoring System by the World Health Organization in 2013. Future applications include concepts including "lab on a chip" and "paper analytical devices" and are claimed to be convenient and simple to use as well as affordable. The principles discussed herein are making profound impact in the fight against substandard and falsified medicines, offering cheap and accessible solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.